BR112017015205A2 - método de prevenção de obesidade e problemas cardiovasculares em aves domésticas - Google Patents

método de prevenção de obesidade e problemas cardiovasculares em aves domésticas

Info

Publication number
BR112017015205A2
BR112017015205A2 BR112017015205A BR112017015205A BR112017015205A2 BR 112017015205 A2 BR112017015205 A2 BR 112017015205A2 BR 112017015205 A BR112017015205 A BR 112017015205A BR 112017015205 A BR112017015205 A BR 112017015205A BR 112017015205 A2 BR112017015205 A2 BR 112017015205A2
Authority
BR
Brazil
Prior art keywords
poultry
obesity
prevention method
cardiovascular problems
cardiovascular
Prior art date
Application number
BR112017015205A
Other languages
English (en)
Other versions
BR112017015205B1 (pt
Inventor
Ei CHEN Shuen
Kiong Chung Thau
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of BR112017015205A2 publication Critical patent/BR112017015205A2/pt
Publication of BR112017015205B1 publication Critical patent/BR112017015205B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/179—Colouring agents, e.g. pigmenting or dyeing agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/807—Poultry or ruminant feed
BR112017015205-3A 2015-01-15 2016-01-15 Uso de uma combinação de 25-hidroxi vitamina d, cantaxantina, vitamina e e vitamina c BR112017015205B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562103769P 2015-01-15 2015-01-15
US62/103,769 2015-01-15
EP15166937 2015-05-08
EP15166937.1 2015-05-08
PCT/EP2016/050751 WO2016113383A1 (en) 2015-01-15 2016-01-15 Method of preventing obesity and cardiovascular problems in poultry

Publications (2)

Publication Number Publication Date
BR112017015205A2 true BR112017015205A2 (pt) 2018-06-19
BR112017015205B1 BR112017015205B1 (pt) 2022-07-19

Family

ID=53051752

Family Applications (6)

Application Number Title Priority Date Filing Date
BR112017015210A BR112017015210A2 (pt) 2015-01-15 2016-01-15 combinação de 25-hidroxi-vitamina d e antioxidantes/anti-inflamatórios para saúde bovina
BR112017015211-8A BR112017015211B1 (pt) 2015-01-15 2016-01-15 Uso da composição de 25-hidroxi-vitamina d e antioxidantes/anti-inflamatórios para promover a saúde do ovário em aves domésticas
BR112017015205-3A BR112017015205B1 (pt) 2015-01-15 2016-01-15 Uso de uma combinação de 25-hidroxi vitamina d, cantaxantina, vitamina e e vitamina c
BR112017015207A BR112017015207A2 (pt) 2015-01-15 2016-01-15 alimento para animais de estimação com combinação de 25-hidroxi-vitamina d e antioxidantes/anti-inflamatórios
BR112017015209A BR112017015209A2 (pt) 2015-01-15 2016-01-15 Alimento para aves domésticas com combinação de 25-hidroxi-vitamina d e antioxidantes/anti- inflamatórios
BR112017015212A BR112017015212A2 (pt) 2015-01-15 2016-01-15 Combinação de 25-hidroxi-vitamina d e anti- inflamatórios para níveis sustentados de 17-\ss estradiol em plasma

Family Applications Before (2)

Application Number Title Priority Date Filing Date
BR112017015210A BR112017015210A2 (pt) 2015-01-15 2016-01-15 combinação de 25-hidroxi-vitamina d e antioxidantes/anti-inflamatórios para saúde bovina
BR112017015211-8A BR112017015211B1 (pt) 2015-01-15 2016-01-15 Uso da composição de 25-hidroxi-vitamina d e antioxidantes/anti-inflamatórios para promover a saúde do ovário em aves domésticas

Family Applications After (3)

Application Number Title Priority Date Filing Date
BR112017015207A BR112017015207A2 (pt) 2015-01-15 2016-01-15 alimento para animais de estimação com combinação de 25-hidroxi-vitamina d e antioxidantes/anti-inflamatórios
BR112017015209A BR112017015209A2 (pt) 2015-01-15 2016-01-15 Alimento para aves domésticas com combinação de 25-hidroxi-vitamina d e antioxidantes/anti- inflamatórios
BR112017015212A BR112017015212A2 (pt) 2015-01-15 2016-01-15 Combinação de 25-hidroxi-vitamina d e anti- inflamatórios para níveis sustentados de 17-\ss estradiol em plasma

Country Status (9)

Country Link
US (7) US10517316B2 (pt)
EP (6) EP3244750A1 (pt)
JP (5) JP6623418B2 (pt)
KR (4) KR20170106328A (pt)
CN (6) CN107105712A (pt)
BR (6) BR112017015210A2 (pt)
CA (1) CA2973431C (pt)
MX (1) MX2017009152A (pt)
WO (6) WO2016113386A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6859570B2 (ja) 2015-01-15 2021-04-14 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． ヒト機能性食品用の２５−ヒドロキシビタミンｄおよび酸化防止剤／抗炎症剤の組み合わせ
CN108935929A (zh) * 2018-06-26 2018-12-07 辽宁禾丰牧业股份有限公司 肉鸡复合预混料及其制备方法
US11723919B2 (en) 2020-06-12 2023-08-15 Phibro Animal Health Corporation Composition or combination comprising anionic dietary supplement and 25-hydroxy vitamin D
CN111657229B (zh) * 2020-06-19 2022-07-29 四川农业大学 一种蛋鸡卵巢氧化应激模型的建立方法
CN113598284A (zh) * 2021-08-16 2021-11-05 广东省农业科学院动物科学研究所 25-oh-vd3在改善卵巢发育和产蛋性能中的应用
CN114164169B (zh) * 2021-11-30 2022-09-13 吉林医药学院 虾青素在促进小鼠腔前卵泡发育中的应用及制剂

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793052A (fr) 1971-12-20 1973-06-20 Upjohn Co Compositions a base de 25-hydroxycholecalciferol, leur preparation et leur utilisation
SU1748784A1 (ru) 1990-12-21 1992-07-23 Московская сельскохозяйственная академия им.К.А.Тимирязева Способ кормлени цыпл т-бройлеров
JPH09294544A (ja) 1996-05-02 1997-11-18 Asao Shimanishi 養鶏用飼料添加剤
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6034075A (en) 1997-03-20 2000-03-07 The Trustees Of Columbia University In The City Of New York Method of treating polycystic ovarian syndrome
JPH1135469A (ja) 1997-07-23 1999-02-09 Teijin Ltd 慢性心不全の予防治療剤
US20100098779A1 (en) 2008-10-22 2010-04-22 Everett Laboratories, Inc. Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects
US7560123B2 (en) 2004-08-12 2009-07-14 Everett Laboratories, Inc. Compositions and methods for nutrition supplementation
US7632518B2 (en) * 2002-01-15 2009-12-15 Dsm Ip Assets B.V. 25-hydroxy vitamin D3 compositions
CN1720030A (zh) * 2002-12-06 2006-01-11 帝斯曼知识产权资产管理有限公司 番茄红素的新用途
US20080070980A1 (en) * 2004-05-18 2008-03-20 Anne Eichinger Use Of Beta-Cryptoxanthin
US20070231371A1 (en) * 2006-02-01 2007-10-04 Nestec, S. A. Nutritional system and methods for increasing longevity
US20100087405A1 (en) 2006-09-14 2010-04-08 Robert Elliott Food supplementation composition containing one or more vitamin d3 compounds and one or more magnesium salts
JP2008106023A (ja) 2006-10-27 2008-05-08 Oriza Yuka Kk エストラジオール生成促進剤
JP5713520B2 (ja) * 2007-07-25 2015-05-07 日清丸紅飼料株式会社 ビタミン類を富化した鶏卵およびその鶏卵の生産方法並びにその鶏卵を生産するために用いる飼料
EA201001288A1 (ru) 2008-02-13 2011-02-28 ДСМ АйПи АССЕТС Б. В. Лечение гипертонии 25-гидроксивитамином d3
BRPI0907950A2 (pt) 2008-02-13 2015-08-04 Dsm Ip Assets Bv Tratamento de hiperglicemia com 25-hidroxivitamina d3
JP2012509253A (ja) * 2008-11-19 2012-04-19 ディーエスエム アイピー アセッツ ビー．ブイ． 家禽における孵化率向上のためのカンタキサンチン及び／又は２５−ｏｈｄ３の使用
GB201013041D0 (en) * 2010-08-03 2010-09-15 Royal Holloway & New Bedford College Carotenoids
CN103260425A (zh) * 2010-12-23 2013-08-21 希尔氏宠物营养品公司 用于体重减轻与保持的宠物食品组合物和方法
CN102038111B (zh) * 2010-12-27 2013-04-24 中牧实业股份有限公司 一种蛋鸡用复合维生素
EP2661632B1 (en) * 2011-01-07 2018-03-07 The General Hospital Corporation Assays and methods of treatment relating to vitamin d insufficiency
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US20160106776A1 (en) * 2013-05-31 2016-04-21 Dsm Ip Assets B.V. Feed supplement and its use
KR102411513B1 (ko) 2013-06-18 2022-06-22 디에스엠 아이피 어셋츠 비.브이. 칸타잔틴의 신규한 용도
CN104171391A (zh) * 2014-07-23 2014-12-03 朱婷婷 肉仔鸡用复合维生素饲料添加剂

Also Published As

Publication number Publication date
KR20170103821A (ko) 2017-09-13
BR112017015212A2 (pt) 2018-06-26
EP3244754A1 (en) 2017-11-22
US20220211077A1 (en) 2022-07-07
JP6623415B2 (ja) 2019-12-25
US20180000124A1 (en) 2018-01-04
KR20170103822A (ko) 2017-09-13
CN107205441A (zh) 2017-09-26
US20180264010A1 (en) 2018-09-20
JP2018504900A (ja) 2018-02-22
KR20170106328A (ko) 2017-09-20
CA2973431A1 (en) 2016-07-21
CN107105712A (zh) 2017-08-29
WO2016113382A1 (en) 2016-07-21
US20180264012A1 (en) 2018-09-20
US10863756B2 (en) 2020-12-15
WO2016113389A1 (en) 2016-07-21
EP3244751A1 (en) 2017-11-22
CA2973431C (en) 2022-07-12
JP2018503372A (ja) 2018-02-08
JP6550651B2 (ja) 2019-07-31
US20180264011A1 (en) 2018-09-20
WO2016113382A9 (en) 2017-03-02
US10517316B2 (en) 2019-12-31
BR112017015207A2 (pt) 2018-06-19
CN107205442A (zh) 2017-09-26
JP2018506962A (ja) 2018-03-15
US20180264009A1 (en) 2018-09-20
JP6623416B2 (ja) 2019-12-25
BR112017015211B1 (pt) 2022-11-22
JP6623418B2 (ja) 2019-12-25
CN107105717A (zh) 2017-08-29
KR20170103824A (ko) 2017-09-13
WO2016113384A1 (en) 2016-07-21
BR112017015210A2 (pt) 2018-06-26
EP3244750A1 (en) 2017-11-22
WO2016113383A1 (en) 2016-07-21
CN107105711A (zh) 2017-08-29
BR112017015211A2 (pt) 2018-06-26
JP2018504106A (ja) 2018-02-15
EP3244755A1 (en) 2017-11-22
BR112017015209A2 (pt) 2018-06-26
EP3244752A1 (en) 2017-11-22
MX2017009152A (es) 2017-10-16
WO2016113385A1 (en) 2016-07-21
JP2018503628A (ja) 2018-02-08
US20180271118A1 (en) 2018-09-27
WO2016113386A1 (en) 2016-07-21
BR112017015205B1 (pt) 2022-07-19
CN107205439A (zh) 2017-09-26
EP3244753A1 (en) 2017-11-22
JP6623417B2 (ja) 2019-12-25

Similar Documents

Publication Publication Date Title
HK1254699A1 (zh) 在硬件中執行核心跨越
DK3339479T3 (da) Elektrolyseindretning og elektrolysefremgangsmåde
GB201604557D0 (en) Flood prevention system and method
BR112017015205A2 (pt) método de prevenção de obesidade e problemas cardiovasculares em aves domésticas
SG11201609273UA (en) Electronic device and method
EP3285237C0 (en) NOTIFICATION DEVICE AND NOTIFICATION METHOD
DK3054744T3 (da) Lederforbindelse og lederforbindelseskomponent
PL3187523T3 (pl) Kopoliwęglan i sposób jego wytwarzania
DK3280423T3 (da) Synergistisk glycocalyx behandlingssammensætninger og fremgangsmåder
EP3113181C0 (en) DECODING APPARATUS AND DECODING METHOD
HK1223194A1 (zh) 表面安裝技術器件及相關方法
PL3170852T3 (pl) Żywica kopoliwęglanowa i sposób jej wytwarzania
SG11201710014QA (en) Affair processing method and device
GB201601942D0 (en) Cache and method
GB2529016B (en) Speech enhancement device and speech enhancement method
GB201702799D0 (en) Prediction method and dietary regime
GB201601062D0 (en) Timetables estimation device and method
JP2016159244A5 (ja) 沈殿槽及び沈殿処理方法
HK1252809A1 (zh) 服務器和程序
HK1199560A1 (en) Data decoding method and device
GB201603140D0 (en) Method and apparatus for back-flow prevention
HK1220676A1 (zh) 配置件和方法
PL3247835T3 (pl) Instalacja przemysłowa i sposób odbarwiania
GB201519443D0 (en) Device and method
EP3548670C0 (en) WALL STRUCTURE AND ASSOCIATED METHOD

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/01/2016, OBSERVADAS AS CONDICOES LEGAIS